Haploinsufficiency ofZNF238is associated with corpus callosum abnormalities in 1q44 deletions

RP58/ZNF238 directly modulates proneurogenic gene levels and is required for neuronal differentiation and brain expansion

(2011) C Xiang et al.   CELL DEATH AND DIFFERENTIATION

Delineation of a deletion region critical for corpus callosal abnormalities in chromosome 1q43–q44

(2011) Sandesh C Sreenath Nagamani et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44

(2011) Blake C. Ballif et al.   HUMAN GENETICS

Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies

(2010) David T. Miller et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Identification of genomic loci contributing to agenesis of the corpus callosum

(2010) Mary C. O'Driscoll et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

ZNF238 Is Expressed in Postmitotic Brain Cells and Inhibits Brain Tumor Growth

(2010) V. M. Tatard et al.   CANCER RESEARCH

Corpus Callosum Abnormalities and the Controversy about the Candidate Genes Located in 1q44

(2010) C. Orellana et al.   CYTOGENETIC AND GENOME RESEARCH

Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene

(2010) Almuth Caliebe et al.   European Journal of Medical Genetics

A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice

(2010) S. Tokuda et al.   HUMAN MOLECULAR GENETICS

The transcriptional repressor RP58 is crucial for cell-division patterning and neuronal survival in the developing cortex

(2009) Haruo Okado et al.   DEVELOPMENTAL BIOLOGY

The array CGH and its clinical applications

(2008) Marwan Shinawi et al.   DRUG DISCOVERY TODAY